Literature DB >> 4367890

Release of prostaglandin by mitogen- and antigen-stimulated leukocytes in culture.

V A Ferraris, F R DeRubertis.   

Abstract

The prostaglandin (PG) content of mitogen- and antigen-stimulated leukocyte cultures was examined by a radioimmunoassay procedure empolying an antiserum reactive with PGB(1) and PGB(2), the alkaline dehydration products of PGE and PGA. At 48 h, mitogen-activated mouse spleen cell cultures showed 2-10-fold increases in the PGE, but not in the PGA, component of immunoreactive PG (iPG) fractionated by silicic acid column chromatography. Increases in iPG were detectable by h 16 in spleen cell cultures incubated with staphylococcal enterotoxin B. Since iPG levels rose only in the culture supernates and not in cells exposed to mitogens for 48 h, increases reflected extracellular release of PG. The validity of the radioimmunoassay determinations of PGE in spleen cell cultures was supported by the results of concomitant assessment of the PGE(2) content of basal and enterotoxin-stimulated cultures by gas chromatography/mass spectrometry. By the latter method, the PGE(2) content was three-fold higher in enterotoxin-activated, compared to basal, cultures at 48 h. Aspirin effectively suppressed increases in both iPG and PGE(2). In spleen cell cultures prepared from mice previously inoculated with an attenuated strain of yellow fever virus in vivo and then incubated with this virus in vitro, iPG levels increased twofold over basal at 48 h. By contrast, iPG content of spleen cell cultures prepared from saline-inoculated mice was not appreciably altered by exposure to the virus in vitro. The enhancement of iPG release from cultured spleen cells by mitogens did not correlate with an ability of these agents to increase cellular cyclic AMP (cAMP) levels. Moreover, epinephrine and cholera toxin markedly increased spleen cell cAMP content but had no demonstrable effect on basal iPG levels, suggesting iPG release from these cells was not mediated by cAMP. Incubation with mitogens also enhanced the iPG content of 72-cultures of human peripheral leukocytes and of human lymphocytes isolated by nylon chromatography. However, the iPG of cultures of human lymphocytes purified by glass bead chromatography and of mouse thymocytes was not appreciably altered when these cells were cultured with mitogens, even though DNA synthesis in both instances was markedly increased. Accordingly, iPG release was not an invariable concomitant of increased DNA synthesis in lymphoid cell cultures. In summary, the results demonstrate that mitogen and antigen stimulation of leukocytes in culture may be accompanied by enhanced release of PGE. The mechanisms mediating this phenomenon and its biologic significance remain to be delineated, but participation of PGE in immunologically induced inflammatory responses seems possible.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4367890      PMCID: PMC301565          DOI: 10.1172/JCI107773

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Prostaglandins: mediators of inflammation?

Authors:  J L Marx
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

Review 2.  Relation of cyclic AMP to the release and actions of prostaglandins.

Authors:  H Shio; J Shaw; P Ramwell
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

Review 3.  Biological significance of the prostaglandins.

Authors:  P W Ramwell; J E Shaw
Journal:  Recent Prog Horm Res       Date:  1970

4.  Prostaglandin E-1: a potential mediator of the inflammatory response.

Authors:  G Kaley; R Weiner
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

5.  Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds.

Authors:  J A Sykes; I S Moddox
Journal:  Nat New Biol       Date:  1972-05-10

6.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

7.  Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin.

Authors:  L Levine; P M Hinkle; E F Voelkel; A H Tashjian
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

8.  The effect of salicylate on the metabolism of normal and stimulated human lymphocytes in vitro.

Authors:  L M Pachman; N B Esterly; R D Peterson
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

9.  Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate.

Authors:  L M Lichtenstein; C S Henney; H R Bourne; W B Greenough
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

10.  Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.

Authors:  J W Smith; A L Steiner; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  25 in total

1.  A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin.

Authors:  M Torbinejad; J Clagett; D Engel
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

2.  Effects of anti-inflammatory drugs on macrophage prostaglandin biosynthesis [proceedings].

Authors:  M A Bray; D Gordon
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  Mitogenic stimulation of murine spleen cells by brief exposure to Staphylococcus aureus enteroxin B.

Authors:  J R Warren
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

4.  In vitro anamnestic immune responses and modulating factors.

Authors:  A B Stavitsky; A A Gerblich
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

5.  Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid.

Authors:  E Vicenzi; A Biondi; C Bordignon; A Rambaldi; M B Donati; A Mantovani
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  Modulation by thymus-derived (T) cells of thyroid cell-stimulated prostaglandin E release by human peripheral blood mononuclear cells.

Authors:  M Yamamoto; N A Takai; B Rapoport; W E Hinds
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Regulation of human immunoglobulin production in vitro by prostaglandin E2.

Authors:  N D Staite; G S Panayi
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo.

Authors:  L M Glode; S E Mergenhagen; D L Rosenstreich
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  Enhancement of lymphocyte blastogenic and delayed hypersensitivity skin responses by indomethacin.

Authors:  C C Muscoplat; P M Rakich; C O Thoen; D W Johnson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

Review 10.  Preclinical studies of antitumor prostaglandins by using human ovarian cancer cells.

Authors:  Y Kikuchi; T Kita; J Hirata; M Fukushima
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.